Bioidentical Hormone Therapy (BHT) may be discussed by perimenopausal and post-menopausal women who want a more personalized alternative to standard hormone treatments. The appeal is personalization: the dose, hormone type, and delivery method can be tailored instead of relying on a single fixed-dose product made for everyone.
What Makes It Different
Most FDA-approved hormone products combine synthetic hormones in set doses that are the same for every patient. Compounded bioidentical hormones are made to be structurally identical to the hormones the body naturally produces.
A compounding pharmacist can adjust the hormone type, strength, and form, such as a cream, gel, capsule, suppository, or tablet, based on what you and your provider decide is right for you. This flexibility is one of the biggest reasons women and their doctors choose this option.
Why Interest in This Has Grown
Interest in bioidentical hormone therapy picked up after a major 2002 study raised concerns about certain synthetic hormone combinations and their health risks in postmenopausal women. Since then, many women and their doctors have moved toward bioidentical options instead.
What the Research Says About Safety
Heart Health Markers
Researchers looked at cholesterol levels, including total cholesterol, triglycerides, LDL, and HDL, as well as blood sugar. These are important indicators of heart health risk. Compounded testosterone and DHEA showed no meaningful negative effect on either compared to placebo.
Blood Pressure and Clotting
There is only limited research here, but a couple of small studies suggested combined hormone therapy and oral DHEA might modestly lower blood pressure. There was not enough data on blood clotting to draw firm conclusions; one short study found no real differences.
Uterine Health
Across several studies, bioidentical hormone therapy did not cause the uterine lining to thicken, which doctors watch closely because a thicker lining can be linked to a higher risk of uterine cancer.
This was true whether BHT was compared to a placebo or to standard FDA-approved hormone products. One thing worth knowing is that these studies measured uterine thickness using ultrasound, not a tissue biopsy, which is the more definitive way to check for abnormal cell changes.
Side Effects
Looking across estrogen, progesterone, testosterone, and DHEA, the overall rate of side effects was similar to placebo. The specific side effects tracked included vaginal spotting, breast tenderness, rash, and androgen-related effects such as acne, excess hair growth (hirsutism), and voice changes.
Differences among BHT preparations included:
- Compounded DHEA was linked to more androgen-related side effects, including acne, hirsutism, and voice changes, than placebo.
- Estrogen, progesterone, and testosterone did not show a meaningful increase in side effects like spotting or breast tenderness.
- Women using bioidentical hormone therapy were not more likely to stop treatment because of side effects.
What the Research Says About Effectiveness
Vaginal Dryness and Atrophy
Vaginal atrophy refers to thinning, drying, and inflammation of the vaginal tissue that happens when estrogen levels drop, usually during and after menopause.
Vaginally applied androgens, such as testosterone and DHEA, showed a real improvement in vaginal atrophy symptoms compared to placebo. Vaginal estrogen on its own did not show a statistically significant improvement specifically for atrophy symptoms, but it did help with related issues like vaginal pH and sexual function.
Sexual Function
Several aspects of sexual function improved with vaginally applied bioidentical hormones, including:
- Arousal
- Lubrication
- Satisfaction
- Less pain during intercourse
- Overall sexual function scores
These improvements were strongest with vaginal testosterone specifically. Oral DHEA, on the other hand, did not show a meaningful improvement in overall sexual function.
Vaginal pH
A healthier, lower vaginal pH, which is linked to less vaginal atrophy, improved with vaginal hormone therapy overall, especially with vaginal estrogen.
Hot Flashes
There is not enough research yet to say whether bioidentical hormone therapy helps with hot flashes or other symptoms like night sweats. Only two small studies looked at this, and the results were mixed.
Bone Health
Across the available studies, mostly using oral DHEA, bioidentical hormone therapy did not show a clear improvement in bone density over 6 months to a year. A couple of individual studies hinted at some benefit, but this did not hold up once the data was combined and analyzed together.
Does Your Body Actually Absorb It?
A common question is whether compounded hormones get absorbed into the bloodstream the way the body would naturally process them. Research showed:
- Low-dose vaginal estrogen, around 10-25 mcg, did not significantly raise blood estrogen levels, meaning it stays mostly local rather than circulating through the whole body. For many women, that can be a safety advantage because it limits broader hormone exposure.
- Vaginal or topical progesterone at higher doses showed more noticeable absorption into the bloodstream.
- Topical testosterone consistently raised blood testosterone levels, and higher doses raised them more.
- Oral DHEA reliably raised DHEA levels in the blood, staying within a range considered safe for postmenopausal women.
- One study compared a compounded oral progesterone to the FDA-approved version, Prometrium, and found similar effects on blood progesterone levels, suggesting the body absorbs them in a comparable way.
Who Might Want to Consider BHT?
Bioidentical hormone therapy may be worth bringing up with your healthcare provider if you:
- Experience vaginal dryness, discomfort, or atrophy related to menopause.
- Have noticed changes in sexual function or satisfaction during perimenopause or menopause.
- Want more say in your dose, hormone type, or delivery method than standard commercial products typically allow.
- Have concerns about the specific hormones or doses used in conventional hormone therapy.
- Prefer a non-oral option, like a cream or gel, over pills.
Important Considerations
- Most of the research available so far is short-term, so we do not have a full picture of what happens with long-term use.
- There is not enough research yet to know how bioidentical hormone therapy affects breast cancer risk, heart attack or stroke risk, or long-term cognitive and mental health.
- Very few studies have directly compared compounded bioidentical hormones to FDA-approved products side by side.
- Like any compounded medication, quality and consistency can vary depending on the pharmacy and the specific formulation used.
- One of the biggest advantages of compounding, adjusting your dose to fit you personally, is not always reflected in research studies, which often use fixed doses for everyone. Real-world results with a personalized dose may look different from what is reported in these studies.
The Bottom Line
Based on the research available so far, bioidentical hormone therapy has not shown major safety concerns when it comes to cholesterol, blood sugar, or uterine health. It looks especially promising for vaginal dryness and sexual function, particularly with vaginal testosterone.
That said, longer studies are still needed to fully understand its effects on heart health and cancer risk over time. As with any hormone therapy, this is a decision worth making together with a provider who knows your health history.
Talk to your healthcare provider or contact Pharmasave Kensington to find out if bioidentical hormone therapy could be right for you.
